HIGHLIGHTS
- who: Lung Adenocarcinoma et al. from the Department of Thoracic Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China have published the paper: Correlation of Tryptophan Metabolic Pathway with Immune Activation and Chemosensitivity in Patients with Lung Adenocarcinoma, in the Journal: Journal of Oncology of 21/09/2022
- what: The authors aimed to figure out the role of tryptophan metabolic pathway in LUAD prognosis and treatment. The aim of this study was to determine the effect of Trp metabolism-related genes on the prognosis of patients with LUAD and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.